- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 11/08 - Bronchodilators
Patent holdings for IPC class A61P 11/08
Total number of patents in this class: 588
10-year publication summary
|
17
|
24
|
32
|
50
|
45
|
45
|
30
|
43
|
31
|
31
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chiesi Farmaceutici S.p.A. | 952 |
26 |
| AstraZeneca AB | 2817 |
16 |
| Almirall, S.A. | 486 |
10 |
| Verona Pharma plc | 39 |
10 |
| Verona Pharma Limited | 75 |
9 |
| Bayer AG | 3560 |
8 |
| Bayer Pharma AG | 1009 |
8 |
| Daiichi Sankyo Company, Limited | 1889 |
8 |
| Insmed Incorporated | 286 |
8 |
| Pulmagen Therapeutics (Synergy) Limited | 20 |
8 |
| Glaxo Group Limited | 4336 |
7 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 780 |
7 |
| Theravance Biopharma R&D IP, LLC | 360 |
7 |
| Vertex Pharmaceuticals Incorporated | 1576 |
6 |
| Ube Industries, Ltd. | 767 |
6 |
| Cipla Limited | 479 |
5 |
| Nippon Shinyaku Co., Ltd. | 325 |
5 |
| Norton (Waterford) Limited | 224 |
5 |
| Respiratorius AB | 10 |
5 |
| Reistone Biopharma Company Limited | 28 |
5 |
| Other owners | 419 |